Results 241 to 250 of about 6,612,897 (317)

Report on the 2nd MObility for Vesicle research in Europe (MOVE) symposium—2024

FEBS Open Bio, EarlyView.
The 2nd MObility for Vesicle research in Europe (MOVE) Symposium in Belgrade brought over 280 attendees from 28 countries to advance extracellular vesicle (EV) research. Featuring keynotes, presentations, and industry sessions, it covered EV biogenesis, biomarkers, therapies, and manufacturing.
Dorival Mendes Rodrigues‐Junior, Michaela Kocholata, Marilena E. Lekka, Olga Janouskova, Moran Yadid, Maja Kosanovic   +5 more
wiley   +1 more source

Extracting drug-drug interactions from biomedical texts

BMC Bioinformatics, 2010
de Pablo-Sánchez César, Martínez Paloma, Segura-Bedmar Isabel   +2 more
doaj   +1 more source

Polypharmacy, drug-drug interactions and adverse drug reactions in older Chinese cancer patients: evidence from CHARLS. [PDF]

Front Pharmacol
Yan Z, Fan KQ, Yu T, Su N, Zou Y, Xia L.
europepmc   +1 more source

DRUG INTERACTIONS AND ANAESTHESIA

, 1978
M. D. Rawlins
openalex   +1 more source

Detection of drug‐drug interactions through data mining studies using clinical sources, scientific literature and social media

Briefings Bioinform., 2018
S. Vilar, C. Friedman, G. Hripcsak
semanticscholar   +1 more source

Identification of amino acids essential for angulin‐1/3 binding of the tricellular tight junction binder, angubindin‐1

FEBS Open Bio, EarlyView.
Angubindin‐1 binds angulin‐1/‐3 at tricellular tight junctions, enhancing intestinal macromolecule permeation. Alanine scanning identified six essential residues (L562, L598, E638, V640, Y643, and K644) of angubindin‐1 critical for binding to angulin‐1/‐3 and permeation‐enhancing activity, providing insights for the development of targeted noninvasive ...
Taiki Kuzu, Yumi Iwashita, Keisuke Tachibana, Itsuki Nishino, Yuki Niwa, Atsuko Uyeda, Kazuki Matsuo, Masahiro Nagahama, Masuo Kondoh   +8 more
wiley   +1 more source

Assessment of Food Effect and pH-Dependent Drug-Drug Interactions of Fruquintinib in Healthy Subjects. [PDF]

Clin Transl Sci
Gonzalez M, Yang Z, Schelman WR, Zhou X, Gupta N, Chien C.   +5 more
europepmc   +1 more source

Interaction of Drugs with Polymers. III. Phase Separation of Polyacids by O-Benzoylthiamine Disulfide Hydrochloride and Gastrointestinal Absorption of O-Benzoylthiamine Disulfide-Polyacid Complexes

, 1970
Nobuo Tanaka, GOICHI HIRATA, Isamu Utsumi   +2 more
openalex   +2 more sources

Short‐term actions of epigalocatechin‐3‐gallate in the liver: a mechanistic insight into hypoglycemic and potential toxic effects

FEBS Open Bio, EarlyView.
Epigallocatechin‐3‐gallate (EGCG) acutely inhibited gluconeogenesis and enhanced glycolysis, glycogenolysis, and fatty acid oxidation in perfused rat livers. Mechanistic assays revealed mitochondrial uncoupling, inhibition of pyruvate carboxylation and glucose‐6‐phosphatase, shift of NADH/NAD+ ratios toward oxidation, and loss of membrane integrity ...
Carla Indianara Bonetti, Bruna Lopes Correia, Francielle Cristina Nakamura Manicardi, Nairana Mithieli de Queiroz Eskuarek Melo, Vanesa de Oliveira Pateis, Jurandir Fernando Comar, Anacharis Babeto de Sá‐Nakanishi, Adelar Bracht, Lívia Bracht   +8 more
wiley   +1 more source

Chat GPT vs. Clinical Decision Support Systems in the Analysis of Drug-Drug Interactions. [PDF]

Clin Pharmacol Ther
Bischof T, Al Jalali V, Zeitlinger M, Jorda A, Hana M, Singeorzan KN, Riesenhuber N, Stemer G, Schoergenhofer C.   +8 more
europepmc   +1 more source